Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
12
IVA Quote, Financials, Valuation and Earnings
Last price:
$2.37
Seasonality move
:
-0.27%
Day range:
$2.29 - $2.35
52-week range:
$1.53 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.03x
P/B ratio:
--
Volume:
2.5K
Avg. volume:
11.6K
1-year change:
-44.05%
Market cap:
$123M
Revenue:
$18.9M
EPS (TTM):
-$2.22
Analysts' Opinion
-
Consensus RatingInventiva SA has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Inventiva SA has an estimated upside of 429.11% from its current price of $2.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $2.35.
Fair Value
-
According to the consensus of 0 analysts, Inventiva SA has 429.11% upside to fair value with a price target of -- per share.
IVA vs. S&P 500
-
Over the past 5 trading days, Inventiva SA has underperformed the S&P 500 by -2.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Inventiva SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Inventiva SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Inventiva SA reported revenues of --.
Earnings Growth
-
Inventiva SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Inventiva SA reported earnings per share of --.
Enterprise value:
162.3M
EV / Invested capital:
--
Price / LTM sales:
7.03x
EV / EBIT:
--
EV / Revenue:
9.65x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-1.77x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-171.62%
Net Income Margin (TTM):
-667.09%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2020-06-30 | 2021-06-30 | |
| Income Statement | ||||||
| Revenue | $3.5M | $6.5M | $345K | $81.5K | $78.3K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$38.4M | -- | -- | -$9.8M | -$16.5M | |
| EBITDA | -$41.5M | -- | -- | -$9.4M | -$16.9M | |
| Diluted EPS | -$1.90 | -- | -- | -$0.25 | -$0.45 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $67.7M | $130.7M | $104.4M | $56.9M | $30.7M | |
| Total Assets | $77.3M | $139.5M | $113.2M | $77M | $42.3M | |
| Current Liabilities | $28.3M | $17.7M | $25.1M | $41.1M | $51.6M | |
| Total Liabilities | $30.4M | $34.1M | $40.4M | $85.3M | $127M | |
| Total Equity | $46.9M | $105.3M | $72.8M | -$8.3M | -$84.7M | |
| Total Debt | -- | -- | $16M | $32.8M | $50.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2020-06-30 | 2021-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$42.6M | -$18.7M | -$31.8M | -$3.9M | -$14.5M | |
| Cash From Investing | -$1.3M | -- | -- | -$1.1M | -$2M | |
| Cash From Financing | -$215.8K | -- | -- | $11M | $56.6K | |
| Free Cash Flow | -$43.1M | -- | -- | -- | -- | |
IVA
Sector
Market Cap
$123M
$44.6M
Price % of 52-Week High
49.47%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
-23.15%
-0.68%
1-Year Price Total Return
-44.05%
-29.09%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.39
200-day SMA
Sell
Level
$2.83
Bollinger Bands (100)
Sell
Level
2.07 - 2.67
Chaikin Money Flow
Sell
Level
-5.8M
20-day SMA
Sell
Level
$2.53
Relative Strength Index (RSI14)
Sell
Level
36.64
ADX Line
Buy
Level
1.15
Williams %R
Neutral
Level
-75.2334
50-day SMA
Sell
Level
$2.59
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
23.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.6147)
Sell
CA Score
(Annual)
Level (-7.4568)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (12.0632)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Stock Forecast FAQ
In the current month, IVA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IVA average analyst price target in the past 3 months is --.
-
Where Will Inventiva SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Inventiva SA share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Inventiva SA?
Analysts are divided on their view about Inventiva SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Inventiva SA is a Sell and believe this share price will drop from its current level to --.
-
What Is Inventiva SA's Price Target?
The price target for Inventiva SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Inventiva SA is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IVA?
You can purchase shares of Inventiva SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Inventiva SA shares.
-
What Is The Inventiva SA Share Price Today?
Inventiva SA was last trading at $2.37 per share. This represents the most recent stock quote for Inventiva SA. Yesterday, Inventiva SA closed at $2.35 per share.
-
How To Buy Inventiva SA Stock Online?
In order to purchase Inventiva SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
